A

Aytu BioPharma
D

AYTU

1.34000
USD
-0.04
(-2.90%)
مغلق
حجم التداول
10,025
الربح لكل سهم
1
العائد الربحي
-
P/E
-1
حجم السوق
8,267,596
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    APT
    0.10000
    (1.82%)
    5.60000 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    O
    OPK
    0.00500
    (0.30%)
    1.67500 USD
    المزيد
الأخبار
المقالات

العنوان: Aytu BioPharma

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidityand a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.